The global market for Rigid Plastic Pharmaceutical Packaging was valued at US$ 29930 million in the year 2024 and is projected to reach a revised size of US$ 49850 million by 2031, growing at a CAGR of 7.7% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rigid Plastic Pharmaceutical Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rigid Plastic Pharmaceutical Packaging.
The Rigid Plastic Pharmaceutical Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rigid Plastic Pharmaceutical Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rigid Plastic Pharmaceutical Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Amcor PIc
Ball Corp.
Becton Dickinson and Co.
Berry Global Group Inc.
Catalent Inc.
Gerresheimer AG
O-I Glass Inc.SCHOTTAG
West Pharmaceutical Services Inc.
WestRock Co.
Segment by Type
Bottles
Blister Packs
Sachets
Syringes
Segment by Application
Medicine
Nutraceuticals
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rigid Plastic Pharmaceutical Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rigid Plastic Pharmaceutical Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 Rigid Plastic Pharmaceutical Packaging by Type
1.2.1 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 Bottles
1.2.3 Blister Packs
1.2.4 Sachets
1.2.5 Syringes
1.3 Rigid Plastic Pharmaceutical Packaging by Application
1.3.1 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Medicine
1.3.3 Nutraceuticals
1.3.4 Others
1.4 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Rigid Plastic Pharmaceutical Packaging Revenue 2020-2031
1.4.2 Global Rigid Plastic Pharmaceutical Packaging Sales 2020-2031
1.4.3 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Rigid Plastic Pharmaceutical Packaging Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global Rigid Plastic Pharmaceutical Packaging Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global Rigid Plastic Pharmaceutical Packaging Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rigid Plastic Pharmaceutical Packaging, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rigid Plastic Pharmaceutical Packaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rigid Plastic Pharmaceutical Packaging, Product Type & Application
2.7 Global Key Manufacturers of Rigid Plastic Pharmaceutical Packaging, Date of Enter into This Industry
2.8 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest Rigid Plastic Pharmaceutical Packaging Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Scenario by Region
3.1 Global Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rigid Plastic Pharmaceutical Packaging Sales by Region: 2020-2031
3.2.1 Global Rigid Plastic Pharmaceutical Packaging Sales by Region: 2020-2025
3.2.2 Global Rigid Plastic Pharmaceutical Packaging Sales by Region: 2026-2031
3.3 Global Rigid Plastic Pharmaceutical Packaging Revenue by Region: 2020-2031
3.3.1 Global Rigid Plastic Pharmaceutical Packaging Revenue by Region: 2020-2025
3.3.2 Global Rigid Plastic Pharmaceutical Packaging Revenue by Region: 2026-2031
3.4 North America Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rigid Plastic Pharmaceutical Packaging Sales by Country (2020-2031)
3.4.3 North America Rigid Plastic Pharmaceutical Packaging Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rigid Plastic Pharmaceutical Packaging Sales by Country (2020-2031)
3.5.3 Europe Rigid Plastic Pharmaceutical Packaging Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rigid Plastic Pharmaceutical Packaging Sales by Region (2020-2031)
3.6.3 Asia Pacific Rigid Plastic Pharmaceutical Packaging Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rigid Plastic Pharmaceutical Packaging Sales by Country (2020-2031)
3.7.3 Latin America Rigid Plastic Pharmaceutical Packaging Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rigid Plastic Pharmaceutical Packaging Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rigid Plastic Pharmaceutical Packaging Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rigid Plastic Pharmaceutical Packaging Sales by Type (2020-2031)
4.1.1 Global Rigid Plastic Pharmaceutical Packaging Sales by Type (2020-2025)
4.1.2 Global Rigid Plastic Pharmaceutical Packaging Sales by Type (2026-2031)
4.1.3 Global Rigid Plastic Pharmaceutical Packaging Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global Rigid Plastic Pharmaceutical Packaging Revenue by Type (2020-2031)
4.2.1 Global Rigid Plastic Pharmaceutical Packaging Revenue by Type (2020-2025)
4.2.2 Global Rigid Plastic Pharmaceutical Packaging Revenue by Type (2026-2031)
4.2.3 Global Rigid Plastic Pharmaceutical Packaging Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global Rigid Plastic Pharmaceutical Packaging Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rigid Plastic Pharmaceutical Packaging Sales by Application (2020-2031)
5.1.1 Global Rigid Plastic Pharmaceutical Packaging Sales by Application (2020-2025)
5.1.2 Global Rigid Plastic Pharmaceutical Packaging Sales by Application (2026-2031)
5.1.3 Global Rigid Plastic Pharmaceutical Packaging Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global Rigid Plastic Pharmaceutical Packaging Revenue by Application (2020-2031)
5.2.1 Global Rigid Plastic Pharmaceutical Packaging Revenue by Application (2020-2025)
5.2.2 Global Rigid Plastic Pharmaceutical Packaging Revenue by Application (2026-2031)
5.2.3 Global Rigid Plastic Pharmaceutical Packaging Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global Rigid Plastic Pharmaceutical Packaging Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amcor PIc
6.1.1 Amcor PIc Company Information
6.1.2 Amcor PIc Description and Business Overview
6.1.3 Amcor PIc Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amcor PIc Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.1.5 Amcor PIc Recent Developments/Updates
6.2 Ball Corp.
6.2.1 Ball Corp. Company Information
6.2.2 Ball Corp. Description and Business Overview
6.2.3 Ball Corp. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ball Corp. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.2.5 Ball Corp. Recent Developments/Updates
6.3 Becton Dickinson and Co.
6.3.1 Becton Dickinson and Co. Company Information
6.3.2 Becton Dickinson and Co. Description and Business Overview
6.3.3 Becton Dickinson and Co. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Becton Dickinson and Co. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.3.5 Becton Dickinson and Co. Recent Developments/Updates
6.4 Berry Global Group Inc.
6.4.1 Berry Global Group Inc. Company Information
6.4.2 Berry Global Group Inc. Description and Business Overview
6.4.3 Berry Global Group Inc. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Berry Global Group Inc. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.4.5 Berry Global Group Inc. Recent Developments/Updates
6.5 Catalent Inc.
6.5.1 Catalent Inc. Company Information
6.5.2 Catalent Inc. Description and Business Overview
6.5.3 Catalent Inc. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Catalent Inc. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.5.5 Catalent Inc. Recent Developments/Updates
6.6 Gerresheimer AG
6.6.1 Gerresheimer AG Company Information
6.6.2 Gerresheimer AG Description and Business Overview
6.6.3 Gerresheimer AG Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gerresheimer AG Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.6.5 Gerresheimer AG Recent Developments/Updates
6.7 O-I Glass Inc.SCHOTTAG
6.7.1 O-I Glass Inc.SCHOTTAG Company Information
6.7.2 O-I Glass Inc.SCHOTTAG Description and Business Overview
6.7.3 O-I Glass Inc.SCHOTTAG Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.7.4 O-I Glass Inc.SCHOTTAG Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.7.5 O-I Glass Inc.SCHOTTAG Recent Developments/Updates
6.8 West Pharmaceutical Services Inc.
6.8.1 West Pharmaceutical Services Inc. Company Information
6.8.2 West Pharmaceutical Services Inc. Description and Business Overview
6.8.3 West Pharmaceutical Services Inc. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.8.4 West Pharmaceutical Services Inc. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.8.5 West Pharmaceutical Services Inc. Recent Developments/Updates
6.9 WestRock Co.
6.9.1 WestRock Co. Company Information
6.9.2 WestRock Co. Description and Business Overview
6.9.3 WestRock Co. Rigid Plastic Pharmaceutical Packaging Sales, Revenue and Gross Margin (2020-2025)
6.9.4 WestRock Co. Rigid Plastic Pharmaceutical Packaging Product Portfolio
6.9.5 WestRock Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rigid Plastic Pharmaceutical Packaging Industry Chain Analysis
7.2 Rigid Plastic Pharmaceutical Packaging Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rigid Plastic Pharmaceutical Packaging Production Mode & Process Analysis
7.4 Rigid Plastic Pharmaceutical Packaging Sales and Âé¶¹Ô´´ing
7.4.1 Rigid Plastic Pharmaceutical Packaging Sales Channels
7.4.2 Rigid Plastic Pharmaceutical Packaging Distributors
7.5 Rigid Plastic Pharmaceutical Packaging Customer Analysis
8 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Dynamics
8.1 Rigid Plastic Pharmaceutical Packaging Industry Trends
8.2 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Drivers
8.3 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Challenges
8.4 Rigid Plastic Pharmaceutical Packaging Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Amcor PIc
Ball Corp.
Becton Dickinson and Co.
Berry Global Group Inc.
Catalent Inc.
Gerresheimer AG
O-I Glass Inc.SCHOTTAG
West Pharmaceutical Services Inc.
WestRock Co.
Ìý
Ìý
*If Applicable.